Stem Cells Products
TARGATT™ Knockin Mice
●
TARGATT™ Embryos
Using our novel TARGATT™ system, a gene of interest can be
specifically inserted at a well-characterized, transcriptionally-active
locus in the mouse genome with guaranteed transgene
expression. Tissue-specific and / or ubiquitous expression options are
available.
Advantages
of TARGATT™ technology:
1.
Site-specific gene integration at a transcriptionally-active
locus ensures high-level gene expression.
2.
Integration happens at an intergenic region; no
internal genes are disrupted.
3. The integrase system catalyzes a unidirectional integration
event and results in a high efficiency in producing transgenic mice.
4. Gene
integration at the same locus allows a precise comparison of the transgenics from one line to another.
● TARGATT™
Kits
● TARGATT™ Supporting Materials
Mouse Embryonic
Fibroblasts (MEF)
● CF-1
● Neo-resistant
● DR4
● SNL (STO feeder cells)
SNL (STO feeder cells)
Click here to see all products
Cell Culture Products
● Germline-tested & ESC-qualified
FBS
● Specialty Media
● Basal Media (DMEM)
● Stem Cell Growth and Differentiation Factors
● ASC Small Molecules
● 3D Culture and Expansion System
Reprogramming
Human Retrovirus microRNA
ESC/iPSC
Characterization
Pluripotency Protein Markers Stem Cell Gene Array
●
Pluripotency mRNA Markers
●
Components
ESC/iPSC Differentiation
● Neural Differentiation
● Dendritic Cell (DC) Generation
ES/iPS Cell Lines
Mouse ES Cell Lines Human iPS
Cells
●
Cell Depository
Primary Cell, cDNA, RNA
(Normal)
●
Endocrine
● Neural
● Pulmonary
● Digestive
● Urinary
● Reproductive
● Skeletal Muscle
● Hematopoietic
● Integumentary
● Cardiovascular
● Miscellaneous
Primary Cell, cDNA, RNA
(Disease)
● Blood Disorders
● Neurological Disorders
● Degenerative Disorders
● Metabolic Disorders
● Cardiovascular Disorders
● Congenital Disorders
● Endocrine Disorders
● Autoimmune Disorders
● Genetic Disorders
● Muscular Disorders
● Oncogenic Disorders
